Malin is buying some time with a shake-up
With its share price slumping, what does ISIF make of Malin’s performance since its 2015 float?
The stock market bull run of the past number years is often pinned on just a handful of technology companies such as Apple, Amazon and Facebook. It’s true they have surged in value, but the other hot sector for investors has been biotech. Driven by innovative technologies and a wall of money, some incredibly important drugs and treatments have been developed, providing huge returns for investors. Tens of millions of dollars of research ...
